These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2888021)

  • 1. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22.
    Rouleau GA; Wertelecki W; Haines JL; Hobbs WJ; Trofatter JA; Seizinger BR; Martuza RL; Superneau DW; Conneally PM; Gusella JF
    Nature; 1987 Sep 17-23; 329(6136):246-8. PubMed ID: 2888021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma.
    Seizinger BR; Martuza RL; Gusella JF
    Nature; 1986 Aug 14-20; 322(6080):644-7. PubMed ID: 3092103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred.
    Wertelecki W; Rouleau GA; Superneau DW; Forehand LW; Williams JP; Haines JL; Gusella JF
    N Engl J Med; 1988 Aug; 319(5):278-83. PubMed ID: 3134615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress towards the isolation and characterization of the genes causing neurofibromatosis.
    Menon AG; Gusella JF; Seizinger BR
    Cancer Surv; 1990; 9(4):689-702. PubMed ID: 2129297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis.
    Seizinger BR; Rouleau G; Ozelius LJ; Lane AH; St George-Hyslop P; Huson S; Gusella JF; Martuza RL
    Science; 1987 Apr; 236(4799):317-9. PubMed ID: 3105060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.
    Rouleau GA; Seizinger BR; Wertelecki W; Haines JL; Superneau DW; Martuza RL; Gusella JF
    Am J Hum Genet; 1990 Feb; 46(2):323-8. PubMed ID: 2105641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurofibromatosis: current clinical and molecular genetic aspects from the neurologic viewpoint].
    Mautner VF; Laute S; Schneider E; Pulst SM
    Nervenarzt; 1991 Jun; 62(6):340-8. PubMed ID: 1678877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
    Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
    Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linkage analysis of Von Recklinghausen neurofibromatosis: chromosomes 4 and 19.
    Dietz JN; Robbins T; Cannon LA; Schwartz CE; Carey JC; Johnson JP; Kivlin J; Skolnick MH
    Genet Epidemiol; 1986; 3(5):313-21. PubMed ID: 3096816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, pathogenesis, and genetics of acoustic tumors.
    Lanser MJ; Sussman SA; Frazer K
    Otolaryngol Clin North Am; 1992 Jun; 25(3):499-520. PubMed ID: 1625863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurofibromatosis--new clinical and molecular genetic aspects].
    Froster-Iskenius UG; Wolff HH
    Hautarzt; 1991 May; 42(5):279-83. PubMed ID: 1678737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
    Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
    Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early childhood diagnosis of acoustic neuromas in presymptomatic individuals at risk for neurofibromatosis 2.
    Pastores GM; Michels VV; Jack CR
    Am J Med Genet; 1991 Dec; 41(3):325-9. PubMed ID: 1789288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.
    Seizinger BR; Rouleau GA; Ozelius LJ; Lane AH; Farmer GE; Lamiell JM; Haines J; Yuen JW; Collins D; Majoor-Krakauer D
    Nature; 1988 Mar; 332(6161):268-9. PubMed ID: 2894613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic linkage analysis of familial amyotrophic lateral sclerosis using human chromosome 21 microsatellite DNA markers.
    Rosen DR; Sapp P; O'Regan J; McKenna-Yasek D; Schlumpf KS; Haines JL; Gusella JF; Horvitz HR; Brown RH
    Am J Med Genet; 1994 May; 51(1):61-9. PubMed ID: 7913294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models for inherited susceptibility to cancer in the nervous system: a molecular-genetic approach to neurofibromatosis.
    Seizinger BR; Martuza RL; Rouleau G; Breakefield XO; Gusella JF
    Dev Neurosci; 1987; 9(3):144-53. PubMed ID: 3119309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A primary genetic linkage map of 14 polymorphic loci for the short arm of human chromosome 8.
    Emi M; Fujiwara Y; Nakamura Y
    Genomics; 1993 Mar; 15(3):530-4. PubMed ID: 8096828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of the gene for familial dysautonomia on chromosome 9 and definition of DNA markers for genetic diagnosis.
    Blumenfeld A; Slaugenhaupt SA; Axelrod FB; Lucente DE; Maayan C; Liebert CB; Ozelius LJ; Trofatter JA; Haines JL; Breakefield XO
    Nat Genet; 1993 Jun; 4(2):160-4. PubMed ID: 8102296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene.
    Seizinger BR; Rouleau GA; Ozelius LJ; Lane AH; Faryniarz AG; Chao MV; Huson S; Korf BR; Parry DM; Pericak-Vance MA
    Cell; 1987 Jun; 49(5):589-94. PubMed ID: 2884037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central neurofibromatosis: a clinical-pathological correlation.
    Grobman LR; Fisch U; Pollack A
    Am J Otol; 1990 Mar; 11(2):108-12. PubMed ID: 2157341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.